← back to search

Robert A. Rissman

University of Southern California · US
🔎 Find collaborators in Physiology · Psychiatry and Mental health →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Neuroinflammation and Neurodegeneration Mechanisms, and Parkinson's Disease Mechanisms and Treatments.
h-index
72
citations
20,636
works
425
NIH funding
primary concept
email

Recent publications

Clinical criteria for limbic‐predominant age‐related TDP‐43 encephalopathy
Alzheimer s & Dementia 2025cited by 63position: middledoi
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study
Alzheimer s & Dementia 2025cited by 48position: middledoi
Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study
Alzheimer s & Dementia 2025cited by 16position: middledoi
Characterization of plasma AT(N) biomarkers among a racial and ethnically diverse community‐based cohort: an HABS‐HD study
Alzheimer s & Dementia Translational Research & Clinical Interventions 2025cited by 14position: middledoi
Health and Aging Brain Study–Health Disparities (HABS‐HD) methods and partner characteristics
Alzheimer s & Dementia Translational Research & Clinical Interventions 2025cited by 14position: middledoi
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing
Nature Communications 2025cited by 13position: middledoi
Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study
Alzheimer s & Dementia 2025cited by 5position: middledoi
Chronic emotional stress and mediating role of Interleukin-6 in the association with cardiometabolic disorders in a multiethnic middle-aged and older US population
International Journal of Cardiology Cardiovascular Risk and Prevention 2025cited by 3position: middledoi
Vulnerability to memory decline in aging revealed by a mega-analysis of structural brain change
Nature Communications 2025cited by 2position: middledoi
Association of Neighborhood‐Level Disadvantage with Cerebrovascular Disease Neuropathology in a National Sample of Brain Donors
Alzheimer s & Dementia 2025cited by 0position: middledoi
Assessment of brain‐derived extracellular vesicle enrichment for blood biomarker analysis in age‐related neurodegenerative diseases: An international overview
Alzheimer s & Dementia 2024cited by 26position: middledoi
Guidelines for the standardization of pre‐analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group
Alzheimer s & Dementia 2024cited by 20position: middledoi
AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
Journal of Neuroinflammation 2024cited by 14position: middledoi
Associations of plasma neurofilament light chain with cognition and neuroimaging measures in community-dwelling early old age men
Alzheimer s Research & Therapy 2024cited by 9position: middledoi
Over‐Representation of Extremely Wealthy Neighborhood Social Exposomes for Brain Donors within Alzheimer’s Disease Research Center Brain Banks assessed by the Neighborhoods Study
Alzheimer s & Dementia 2024cited by 0position: middledoi
Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease
Alzheimer s & Dementia 2023cited by 137position: firstdoi
Characterization of altered molecular mechanisms in Parkinson’s disease through cell type–resolved multiomics analyses
Science Advances 2023cited by 92position: middledoi
Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus
Alzheimer s & Dementia 2023cited by 86position: middledoi
Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions
Alzheimer s & Dementia 2023cited by 49position: middledoi
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD
Science Translational Medicine 2023cited by 32position: middledoi
Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease
Alzheimer s & Dementia 2023cited by 32position: middledoi
Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US
JAMA Network Open 2023cited by 19position: middledoi
The heritability of blood‐based biomarkers related to risk of Alzheimer's disease in a population‐based sample of early old‐age men
Alzheimer s & Dementia 2023cited by 15position: middledoi
Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease
Neurobiology of Disease 2023cited by 12position: lastdoi
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease
Alzheimer s & Dementia 2022cited by 246position: middledoi
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Acta Neuropathologica 2022cited by 225position: middledoi
LATE-NC staging in routine neuropathologic diagnosis: an update
Acta Neuropathologica 2022cited by 172position: middledoi
Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial
Scientific Reports 2022cited by 64position: middledoi
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome
JAMA Neurology 2022cited by 53position: middledoi
Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non‐Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2022cited by 38position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eliezer Masliah · Institute on Aging15 papers (2016–2023)Charisse N. Winston · University of Southern California11 papers (2016–2024)Michael S. Rafii · University of Southern California10 papers (2015–2023)Edward Rockenstein · University of California San Diego9 papers (2016–2021)Sid E. O’Bryant · University of North Texas9 papers (2015–2025)Brian Spencer · University of Southern California9 papers (2017–2023)Anthony Adame · University of California, San Diego9 papers (2017–2021)Changyoun Kim · National Institutes of Health8 papers (2017–2023)James Hall · University of North Texas8 papers (2015–2025)James B. Brewer · University of California San Diego8 papers (2016–2025)Michael Mante · University of California San Diego7 papers (2017–2021)Michael Donohue · University of Southern California6 papers (2015–2023)Kristine Yaffe · Icahn School of Medicine at Mount Sinai6 papers (2021–2025)Rema Raman · ADS Group6 papers (2019–2023)Melissa Petersen · University of North Texas6 papers (2021–2025)Leigh Johnson · University of North Texas6 papers (2021–2025)Paul Aisen · University of Southern California6 papers (2018–2022) · 5 papers (2018–2023)Douglas Galasko · La Jolla Bioengineering Institute5 papers (2016–2022)Fan Zhang · University of Vermont5 papers (2015–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Physiology · Psychiatry and Mental health →